Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 34

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 53–58

Modern anticoagulants in the treatment and prevention of thrombotic complications in patients with Hodgkin’s lymphoma

Introduction. Cancer patients have a high risk of developing venous thromboembolic complications, which worsen the outcomes of antitumor treatment and are the second leading cause of death after cancer progression. Objectives – to assess the effect of modern a…

10.29296/24999490-2026-03-07Details ↗
ОБЗОР2025 · pp. 55–63

Neurotoxic complications of cancer chemotherapy

Introduction. Neurotoxicity is a common complication of chemotherapy that negatively affects the quality of life of cancer patients. Damage to the nervous system affects both the peripheral nerves (peripheral neuropathy) and the central nervous system (chemo b…

10.29296/24999490-2025-04-09Details ↗
ОБЗОР2025 · pp. 30–38

Molecular mechanisms of action of natural bioactive compounds in personalized medicine for the rehabilitation of cancer patients after chemo and radiation therapy

The purpose of the study. To analyze scientific data on the molecular targets and mechanisms of action of key natural bioactive substances used to support cancer patients after chemotherapy and radiation therapy in the framework of personalized medicine. Perso…

10.29296/24999490-2025-03-04Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 40–47

COMPARATIVE ANALYSIS OF THE DIAGNOSTIC ACCURACY OF ENDOSTATIN AND VEGF SERUM LEVELS IN PATIENTS WITH BONE SARCOMAS

Introduction. Angiogenesis regulators are of particular interest as new serum markers in cancer patients, since they reflect the intensity of tumor growth and metastasis. Currently, many works are dedicated to the study of vascular endothelial growth factor (V…

10.29296/24999490-2024-05-05Details ↗
ОБЗОР2023 · pp. 11–19

THE ROLE OF CHROMOSOMAL V(D)J RECOMBINATION OF LYMPHOCYTES IN THE FORMATION OF ANTITUMOR IMMUNITY AND THE EFFECTIVENESS OF IMMUNOTHERAPY

Introduction. The effectiveness of antitumor immunity is determined by various mechanisms of recognition of tumor antigens, while the diversity of the repertoire of antigenic receptors is determined by V(D)J recombinations in maturing T and B cells. The aim of…

10.29296/24999490-2023-04-02Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2021

PHASE I CLINICAL STUDY OF A NEW RADIOPHARMACEUTICAL BASED ON RECOMBINANT TARGET MOLECULES DARPIN9_29 LABELED WITH 99mTECHNETIUM FOR RADIONUCLIDE DIAGNOSIS OF THE Her2/neu-POSITIVE BREAST CANCER

Introduction. The main attention of researchers is paid to the study of one of the members of the EGF family – the receptor of epidermal growth factor 2 (Her2/neu), the overexpression of which is detected in 15–20% of cases of invasive breast cancer and had an…

10.29296/24999490-2021-02-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2021

SINGLE-PHOTON EMISSION COMPUTERIZED TOMOGRAPHY WITH 99mTc-DARPin9_29 IN DIAGNOSTICS OF BREAST CANCER WITH Her2/neu OVEREXPRESSION: FIRST CLINICAL EXPЕRIENCE

Introduction. In recent years, alternative framework proteins are used for the targeted radionuclide imaging. Molecules of DARPin (Design Ankyrin Repeat Protein) are one of the representatives of scaffolds. Despite the continued increase in the number of molec…

10.29296/24999490-2021-01-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020

PROTECTIVE EFFECT OF BIOREGULATORY PEPTIDES ON THE ORGANOTYPIC TISSUE CULTURE DEVELOPMENT IN CYTOSTATIC PRESENCE

Introduction. The delay of the adverse events by the use of drugs is an actual medicine task. The cytostatics inhibiting cellular proliferation, are using in a clinic for the hindering tumor development. Thus, the adverse events occur due to the damage of heal…

10.29296/24999490-2020-06-08Details ↗
ОБЗОР2019

PD-1 PATH: BIOLOGICAL SIGNIFICANCE, CLINICAL APPLICATION, AND EXISTING PROBLEMS

The review is devoted to the studies of immune check-point (programmed death) molecules – PD-1 receptor and its ligands PD-L1 and PD-L2, which play an important role in the regulation of immune response. Special attention is paid to soluble (s) forms of PD-1 a…

10.29296/24999490-2019-01-01Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2019

ACTIVATING POINT MUTATION OF BRCA1/2 GENES IN AZERBAIJAN POPULATION

Introduction. Breast cancer is the leading cancer type among woman of Azerbaijan population. Hereditary mutations of the BRCA1/2 genes are considered as high risk for appeared breast and ovarian cancers. In Azerbaijan BRCA1/2-related breast and ovarian cancer …

10.29296/24999490-2019-02-05Details ↗
ОБЗОР2019

THE ROLE OF NF-κB AND von HIPPEL-LINDAU PROTEIN IN THE CREATION OF A MOLECULAR PORTRAIT OF KIDNEY CANCERS

The review presents data on the role of the nuclear factor NF-κB and the von Hippel-Lindau protein (VHL) in the development of kidney cancer. Chemo- and radioresistance, specific for renal cell carcinoma, represented a significant problem in the treatment of p…

10.29296/24999490-2019-03-03Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2017

CLINICAL IMPLICATION OF SERUM INSULIN-LIKE GROWTH FACTORS (IGF) AND IGF BINDING PROTEINS IN COLORECTAL CANCER PATIENTS

Introduction. Insulin-like growth factor (IGF) signaling system plays a major role in development and progression of various malignant tumors including colorectal cancer (CRC), so far its components are considered as potential diagnostic and prognostic markers…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

ASSOCIATION BETWEEN XRCC1 ARG399GLN AND P53 ARG72PRO POLYMORPHIC MARKERS AND THE RISK OF BREAST CANCER RISK IN KYRGYZ WOMEN

Aim. To investigate the possible association between XRCC1 Arg399Gln and p53 Arg72Pro polymorphism and the risk of breast cancer (BC) risk in Kyrgyz women. Methods. The XRCC1 Arg399Gln and p53 Arg72Pro genotypes were determined with the use of the polymerase c…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

TNF GENE POLYMORPHISMS AFFECT THE PROGRESSION OF THE DISEASE IN BREAST CANCER PATIENTS

Introduction. Tumor necrosis factor (TNF) plays a central role in the development of inflammatory and neoplastic processes. In the TNF gene promoter region there are -308(g/a) and -238(G/A) polymorphisms with different influence on the level of expression of T…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

MOLECULAR AND CELLULAR FACTORS OF LOCAL IMMUNITY IN ASCITIC FLUID OF OVARIAN CANCER PATIENTS

Introduction. Immunologic microenvironment of malignant tumors is likely to be significant in «tumor-host» interaction. The aim of the study. Сomparative analysis of systemic and local factors of cellular and humoral immunity in patients with ascitic forms of …

Details ↗
ОБЗОР2016

MICRORNAS AS BIOLOGICAL MARKERS OF OVARIAN CANCER

MicroRNAs (miRNAs) – small non-coding RNAs targeting multiple mRNAs – are posttranscriptional regulators of gene expression involved in carcinogenesis, metastasis, and invasion. MiRNAs expression is altered in various human tumors including ovarian cancer. Ana…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

ASSOCIATION OF CANCER MOLECULAR PARAMETERS WITH EFFECTIVENESS OF PAZOPANIB TREATMENT IN ADVANCED KIDNEY CANCER PATIENTS

Introduction. The search for criteria for the prediction of the efficacy of targeted therapies will allow not only to optimize the readings, but also to improve the results of treatment of patients with metastatic kidney cancer. The aim of the study is the inv…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

THE INSULINE-LIKE GROWTH FACTOR SYSTEM IN OVARIAN CANCER METASTASIS: THE RELATION WITH P45 SER Β-CATENIN

Introduction: Insulin-like growth factors (IGFs), insulin-like growth factor-I receptor (IGF-IR), IGR-binding proteins (IGFBPs) and IGBP proteases can play an important role in the development of metastases in ovarian cancer. The relationship between IGF syste…

Details ↗

Article search and quick navigation

Navigation